Sort
141,003 grants matching “cytokine”
Evaluating the role of P53 pathways in malaria
$685,219Tuan Manh Tran · Indiana University Indianapolis · R01 · FY2025 · AI
Genetics of IgA nephropathy by integrative network-based association studies
$685,217Krzysztof Kiryluk · Columbia University Health Sciences · R01 · FY2023 · DK
Tolerance Induction for Primate Islet Transplantation
$685,189Massachusetts General Hospital · U01 · FY2004 · AI
Evaluating the protective effect of a tissue selective estrogen complex (TSEC) in women with newly diagnosed ductal carcinoma in situ
$685,186Swati Kulkarni · Northwestern University At Chicago · R01 · FY2018 · CA
Tumor-derived extracellular vesicles in the pre-metastatic niche.
$685,156Yves A Declerck · Children'S Hospital Of Los Angeles · R01 · FY2025 · CA
Deciphering the Mechanism of Lymphovascular Space Invasion Using a Lymphovascularized Bioengineering Breast Stromal Platform
$685,125Marissa Nichole Rylander · University Of Texas At Austin · R01 · FY2025 · CA
Chemoproteomic-Enabled Strategy to Study SLC Transporter Roles in Inflammation
$685,123Christopher G Parker · Scripps Research Institute, The · R01 · FY2024 · AI
Chemoproteomic-Enabled Strategy to Study SLC Transporter Roles in Inflammation
$685,123Christopher G Parker · Scripps Research Institute, The · R01 · FY2022 · AI
Chemoproteomic-Enabled Strategy to Study SLC Transporter Roles in Inflammation
$685,123Christopher G Parker · Scripps Research Institute, The · R01 · FY2023 · AI
The Molecular Profile of Prostate Tumors in African-American Men
$685,102Stefan Ambs · Division Of Basic Sciences - Nci · ZIA · FY2022 · CA
Development Of A Vaccine For Leishmania Major Infection
$685,037Robert A Seder · National Institute Of Allergy And Infectious Diseases · ZIA · FY2011 · AI
Immunologic basis of cardiac disease after severe COVID-19
$685,031Chetan N Shenoy · University Of Minnesota · R01 · FY2023 · HL
Dengue-Zika: Correlates of Cross-Protection in Non-Human Primates
$685,020Carlos A Sariol · University Of Puerto Rico Med Sciences · R01 · FY2022 · AI
Viral and allergen-driven immunity in chronic lung disease
$684,921Nicholas W Lukacs · University Of Michigan At Ann Arbor · R35 · FY2021 · HL
Viral and allergen-driven immunity in chronic lung disease
$684,921Nicholas W Lukacs · University Of Michigan At Ann Arbor · R35 · FY2022 · HL
Viral and allergen-driven immunity in chronic lung disease
$684,921Nicholas W Lukacs · University Of Michigan At Ann Arbor · R35 · FY2020 · HL
Viral and allergen-driven immunity in chronic lung disease
$684,921Nicholas W Lukacs · University Of Michigan At Ann Arbor · R35 · FY2023 · HL
Viral and allergen-driven immunity in chronic lung disease
$684,921Nicholas W Lukacs · University Of Michigan At Ann Arbor · R35 · FY2025 · HL
VITAMIN D AND IMMUNOMODULATION IN CORONARY ARTERY DISEASE
$684,894Devendra K. Agrawal · Creighton University · R01 · FY2015 · HL
The development of a recombinant vaccine against human onchocerciasis
$684,875Sara Lustigman · New York Blood Center · R01 · FY2020 · AI
Studies of Retinopathy of AIDS in the HAART Era
$684,843William R. Freeman · University Of California, San Diego · R01 · FY2011 · EY
Role of MIF and CD74 in the pathogenesis of emphysema
$684,815Maor Sauler · Yale University · R01 · FY2021 · HL
Role of MIF and CD74 in the pathogenesis of emphysema
$684,815Maor Sauler · Yale University · R01 · FY2022 · HL
Role of MIF and CD74 in the pathogenesis of emphysema
$684,815Maor Sauler · Yale University · R01 · FY2023 · HL
Role of MIF and CD74 in the pathogenesis of emphysema
$684,815Maor Sauler · Yale University · R01 · FY2025 · HL